Analystreport

Heron Therapeutics Inc (NASDAQ: HRTX) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus.

Heron Therapeutics, Inc.  (HRTX) 
Last heron therapeutics, inc. earnings: 3/2 07:30 am Check Earnings Report
US:NASDAQ Investor Relations: herontherapeutics.gcs-web.com/investor-home